TY - JOUR
T1 - Microfluidic mixing probe
T2 - generating multiple concentration-varying flow dipoles
AU - Ali, Dima Samer
AU - Glia, Ayoub
AU - Sukumar, Pavithra
AU - Deliorman, Muhammedin
AU - Qasaimeh, Mohammad A.
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/12
Y1 - 2025/12
N2 - This study advances microfluidic probe (MFP) technology through the development of a 3D-printed Microfluidic Mixing Probe (MMP), which integrates a built-in pre-mixer network of channels and features a lined array of paired injection and aspiration apertures. By combining the concepts of hydrodynamic flow confinements (HFCs) and “Christmas-tree” concentration gradient generation, the MMP can produce multiple concentration-varying flow dipoles, ranging from 0 to 100%, within an open microfluidic environment. This innovation overcomes previous limitations of MFPs, which only produced homogeneous bioreagents, by utilizing the pre-mixer to create distinct concentration of injected biochemicals. Experimental results with fluorescent dyes and the chemotherapeutic agent Cisplatin on MCF-7 cells confirmed the MMP’s ability to generate precise, discrete concentration gradients with the formed flow dipoles, consistent with numerical models. The MMP’s ability to localize drug exposure across cell cultures without cross-contamination opens new avenues for drug testing, personalized medicine, and molecular biology. It enables precise control over gradient delivery, dosage, and timing, which are key factors in enhancing drug evaluation processes.
AB - This study advances microfluidic probe (MFP) technology through the development of a 3D-printed Microfluidic Mixing Probe (MMP), which integrates a built-in pre-mixer network of channels and features a lined array of paired injection and aspiration apertures. By combining the concepts of hydrodynamic flow confinements (HFCs) and “Christmas-tree” concentration gradient generation, the MMP can produce multiple concentration-varying flow dipoles, ranging from 0 to 100%, within an open microfluidic environment. This innovation overcomes previous limitations of MFPs, which only produced homogeneous bioreagents, by utilizing the pre-mixer to create distinct concentration of injected biochemicals. Experimental results with fluorescent dyes and the chemotherapeutic agent Cisplatin on MCF-7 cells confirmed the MMP’s ability to generate precise, discrete concentration gradients with the formed flow dipoles, consistent with numerical models. The MMP’s ability to localize drug exposure across cell cultures without cross-contamination opens new avenues for drug testing, personalized medicine, and molecular biology. It enables precise control over gradient delivery, dosage, and timing, which are key factors in enhancing drug evaluation processes.
UR - https://www.scopus.com/pages/publications/85216269211
U2 - 10.1038/s41598-025-85797-3
DO - 10.1038/s41598-025-85797-3
M3 - Article
C2 - 39824991
AN - SCOPUS:85216269211
SN - 2045-2322
VL - 15
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 2252
ER -